AI
Monday, January 26, 2026 11:42:56 AM
Thanks for posting your free valuation analysis. Before we all recalibrate reality, what do you estimate the annual worldwide value of checkpoint inhibitors is? 😶
Fact ✅️:
Two of NWBO’s pipeline products are currently in clinical trials with Merck’s pembrolizumab, & Roswell partnered with NWBO for a licensing deal…
In addition to DCVax®-L at UCLA, Roswell’s aDC1platform has also reached Phase II in COMBO with commercial drugs (checkpoint inhibitors & TLR agonists).
For example, This Roswell PII clinical trial is active & posted an update on Dec 30th. Moffitt is included on its list of trial sites, & it’s funded by a peer-reviewed grant awarded by the 🇺🇸U.S. DoD:
ASCO 2025
Dr. Kalinski
⭐️Combo is King!⭐️
DCVax-L Combo PII UCLA
AI Fact-Checking
I am a long NWBO shareholder. Views expressed are my own, and I have no affiliation with the company.
Recent NWBO News
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
